☰

Amit Tuli, Ph.D. - Publications

Affiliations: 
2009 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Immunology, Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC. Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget. PMID 26840089 DOI: 10.18632/Oncotarget.7103  0.751
2015 Michelet X, Garg S, Wolf BJ, Tuli A, Ricciardi-Castagnoli P, Brenner MB. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b. Journal of Immunology (Baltimore, Md. : 1950). 194: 2079-88. PMID 25637027 DOI: 10.4049/Jimmunol.1401072  0.441
2013 Tuli A, Thiery J, James AM, Michelet X, Sharma M, Garg S, Sanborn KB, Orange JS, Lieberman J, Brenner MB. Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity. Molecular Biology of the Cell. 24: 3721-35. PMID 24088571 DOI: 10.1091/Mbc.E13-05-0259  0.366
2012 Peters HL, Tuli A, Wang X, Liu C, Pan Z, Ouellette MM, Hollingsworth MA, Macdonald RG, Solheim JC. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. International Journal of Oncology. 41: 1464-74. PMID 22797723 DOI: 10.3892/Ijo.2012.1553  0.758
2012 Simone LC, Tuli A, Simone PD, Wang X, Solheim JC. Analysis of major histocompatibility complex class I folding: novel insights into intermediate forms. Tissue Antigens. 79: 249-62. PMID 22329842 DOI: 10.1111/J.1399-0039.2012.01849.X  0.787
2011 Peters HL, Tuli A, Sharma M, Naslavsky N, Caplan S, MacDonald RG, Solheim JC. Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2. Immunologic Research. 51: 39-44. PMID 21826533 DOI: 10.1007/S12026-011-8238-6  0.801
2011 Garg S, Sharma M, Ung C, Tuli A, Barral DC, Hava DL, Veerapen N, Besra GS, Hacohen N, Brenner MB. Lysosomal trafficking, antigen presentation, and microbial killing are controlled by the Arf-like GTPase Arl8b. Immunity. 35: 182-93. PMID 21802320 DOI: 10.1016/J.Immuni.2011.06.009  0.356
2010 Simone LC, Wang X, Tuli A, Solheim JC. Effect of a tapasin mutant on the assembly of the mouse MHC class I molecule H2-K(d). Immunology and Cell Biology. 88: 57-62. PMID 19687800 DOI: 10.1038/Icb.2009.59  0.803
2009 Tuli A, Sharma M, Capek HL, Naslavsky N, Caplan S, Solheim JC. Mechanism for amyloid precursor-like protein 2 enhancement of major histocompatibility complex class I molecule degradation. The Journal of Biological Chemistry. 284: 34296-307. PMID 19808674 DOI: 10.1074/Jbc.M109.039727  0.701
2009 Wang X, Simone LC, Tuli A, Solheim JC. Comparative analysis of the impact of a free cysteine in tapasin on the maturation and surface expression of murine MHC class I allotypes. International Journal of Immunogenetics. 36: 183-7. PMID 19490214 DOI: 10.1111/J.1744-313X.2009.00840.X  0.807
2009 Tuli A, Sharma M, Wang X, Simone LC, Capek HL, Cate S, Hildebrand WH, Naslavsky N, Caplan S, Solheim JC. Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunology, Immunotherapy : Cii. 58: 1419-31. PMID 19184004 DOI: 10.1007/S00262-009-0657-Z  0.814
2009 Simone LC, Wang X, Tuli A, McIlhaney MM, Solheim JC. Influence of the tapasin C terminus on the assembly of MHC class I allotypes. Immunogenetics. 61: 43-54. PMID 18958466 DOI: 10.1007/S00251-008-0335-X  0.805
2009 Lin X, Wang X, Capek HL, Simone LC, Tuli A, Morris CR, Reber AJ, Solheim JC. Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines. Cancer Immunology, Immunotherapy : Cii. 58: 729-36. PMID 18828016 DOI: 10.1007/S00262-008-0595-1  0.749
2009 Tuli A, Sharma M, Wang X, Simone LC, Capek HL, Cate S, Hildebrand WH, Naslavsky N, Caplan S, Solheim JC. Erratum to: Amyloid precursor-like protein 2 association with HLA class I molecules Cancer Immunology, Immunotherapy. 59: 339-339. DOI: 10.1007/S00262-009-0777-5  0.789
2008 Tuli A, Sharma M, McIlhaney MM, Talmadge JE, Naslavsky N, Caplan S, Solheim JC. Amyloid precursor-like protein 2 increases the endocytosis, instability, and turnover of the H2-K(d) MHC class I molecule. Journal of Immunology (Baltimore, Md. : 1950). 181: 1978-87. PMID 18641335 DOI: 10.4049/Jimmunol.181.3.1978  0.726
2008 Tuli A, Sharma M, Naslavsky N, Caplan S, Solheim JC. Specificity of amyloid precursor-like protein 2 interactions with MHC class I molecules. Immunogenetics. 60: 303-13. PMID 18452037 DOI: 10.1007/S00251-008-0296-0  0.732
2007 Ashour AE, Lin X, Wang X, Turnquist HR, Burns NM, Tuli A, Sadanandam A, Suleiman K, Singh RK, Talmadge JE, Solheim JC. CCL21 is an effective surgical neoadjuvant for treatment of mammary tumors. Cancer Biology & Therapy. 6: 1206-10. PMID 17617742 DOI: 10.4161/Cbt.6.8.4405  0.68
Show low-probability matches.